| Dishman Carbogen Amcis Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540701 |
NSE Symbol : DCAL |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE385W01011 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 253.26 |
Market Cap(₹Cr) : 3,525.27 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 60.30 | 62.86 | 106.10 | 97.04 | 93.29 | 103.41 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 60.30 | 62.86 | 106.10 | 97.04 | 93.29 | 103.41 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 11.17 | 37.42 | 5.47 | -8.01 | 23.93 | 11.59 |
| Total Income | 71.47 | 100.28 | 111.57 | 89.03 | 117.22 | 115.00 |
| Total Expenditure | 55.89 | 59.43 | 85.57 | 74.08 | 79.89 | 88.51 |
| PBIDT | 15.58 | 40.85 | 26.00 | 14.95 | 37.33 | 26.49 |
| Interest | 20.61 | 20.26 | 21.31 | 17.77 | 15.59 | 15.73 |
| PBDT | -5.03 | 20.59 | 4.69 | -2.82 | 21.74 | 10.76 |
| Depreciation | 15.79 | 16.47 | 16.10 | 16.48 | 16.30 | 16.32 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -7.22 | 1.45 | -4.04 | -6.02 | -8.81 | -2.09 |
| Reported Profit After Tax | -13.60 | 2.67 | -7.37 | -13.28 | 14.25 | -3.47 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -13.60 | 2.67 | -7.37 | -13.28 | 14.25 | -3.47 |
| EPS (Unit Curr.) | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 | -0.22 |
| EPS (Adj) (Unit Curr.) | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 | -0.22 |
| Calculated EPS (Unit Curr.) | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 | -0.22 |
| Calculated EPS (Adj) (Unit Curr.) | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 | -0.22 |
| Calculated EPS (Ann.) (Unit Curr.) | -3.47 | 0.68 | -1.88 | -3.39 | 3.64 | -0.89 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -3.47 | 0.68 | -1.88 | -3.39 | 3.64 | -0.89 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 31.36 | 31.36 | 31.36 | 31.36 | 31.36 | 31.36 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.84 | 64.99 | 24.51 | 15.41 | 40.02 | 25.62 |
| PBDTM(%) | -8.34 | 32.76 | 4.42 | -2.91 | 23.30 | 10.41 |
| PATM(%) | -22.55 | 4.25 | -6.95 | -13.69 | 15.27 | -3.36 |